We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Judge Approves $264 million Mylan/Viatris Settlement Over High EpiPen Prices
Judge Approves $264 million Mylan/Viatris Settlement Over High EpiPen Prices
Viatris, formerly Mylan, now must pay out a settlement of $264 million to consumers, insurers and pension funds who sued the company over steep price spikes for EpiPen, which is used to quickly administer epinephrine to treat potentially fatal allergic reactions.